Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
about
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acidAdvances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaFocal liver lesions: Practical magnetic resonance imaging approachThe role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a reviewRadiological diagnosis of hepatocellular carcinomaRecent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRIConsensus report from the 7th International Forum for Liver Magnetic Resonance ImagingMajor and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection.Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.T2* Mapping from Multi-Echo Dixon Sequence on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Hepatic Fat Quantification: Can It Be Used for Hepatic Function Assessment?MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score.Hepatocellular carcinoma: early-stage management challengesIs 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging featuresCharacterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imagingGadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysisAdded value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensityConsensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance ImagingGadoxetic acid disodium (Gd-EOBDTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis.Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter studyCombined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.Gd-EOB-DTPA-enhanced and diffusion-weighted magnetic resonance findings in hepatic epithelioid angiomyolipoma: A case report.Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver MetastasisDifferentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC)Safety and Efficacy of Gadoxetate Disodium-Enhanced Liver MRI in Pediatric Patients Aged >2 Months to <18 Years-Results of a Retrospective, Multicenter StudyDiagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference StandardAdded value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT).Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR imagesHepatocarcinogenesis: imaging-pathologic correlation.
P2860
Q26769602-2336A7FF-F65D-4F2F-97A8-1524DA2B5C3EQ26772334-A039E8E9-C417-43FA-A409-74E343DDCEBAQ26799474-BA0E15F3-8A3F-4477-99C0-D0DE20BAE243Q26828543-7B267BA7-19F6-49A4-BEE5-B43CAE3D5F37Q27027683-B6F02999-7198-4D9B-AADA-AD587F572CF1Q28075361-2E185A38-D4AA-497A-8C00-FBBD2A86A57EQ28088807-30CC6F43-7128-4A06-9265-CAEB9995A6ECQ33617869-FF35E66F-5D6D-4734-8BD2-DFF713513007Q33720913-A2EC5B9E-1411-45B0-BFA9-3621F2B8FB90Q33728121-703747B6-336C-4895-949C-D006AB6E4B44Q33736343-78444E04-A154-4815-B571-A09007C27C8DQ33858748-072F46BA-2FB4-420B-8FD4-73FCD867774EQ33881131-CCAA6FF4-B301-408D-B391-B34EC4CF48B3Q34466458-16BD2963-9266-4473-AA7E-1398757AE726Q34682228-154170A7-654E-484B-B6BE-B11D07C9422BQ34776353-76F9F891-7D22-4E7F-B0EB-AB5CA664CA61Q34963150-F5305459-A1D9-4350-8FF5-75C74816BE7DQ35056708-D388D7FA-0DB5-4B11-9A67-D723E88EBE5BQ35072802-CDF9E7EB-B0B5-40D6-9370-4E5F4D845CF6Q35148664-B7635FEB-8161-4E47-95EA-DA00EA31A87AQ35203565-A6EAA21D-4D76-48E2-AFA2-D2EA414B40E7Q35207733-84C8EC0B-B62C-4F8D-88D8-B27B5627F214Q35207736-E65A2545-79BB-4727-BCAB-4F636BA71771Q35570797-5F74C191-AECA-47E3-B502-BB750AB03A39Q35858656-9C733618-F0C7-4C93-8597-5ADF381CA5F3Q35871278-70CA439C-32C2-484C-9BBC-CEFCDABC7E7DQ35909487-194F4F3C-DE14-4B38-A596-8D8168EF4141Q36051492-F1188516-D634-465B-ABE4-10C0C45C8C3CQ36133194-7BAA1A3E-5017-44A2-AF78-A196107763F5Q36325824-F9D6073B-4154-4CEF-97BD-7249D6120864Q36688101-14B1FAA4-DBED-4847-AC2D-423A8F702908Q37118749-1F685C6A-4BC5-4F4F-95AF-A80F667BDC48Q37129627-84B96F37-5E81-4B83-B9AC-629C1A2F755AQ37378960-C167F66B-98A0-4B49-A5F7-F92FCBF848C6Q37605822-F840CB5E-5A46-4B82-98E5-C39D27EE1E12Q37631122-DB576325-49DD-4747-B04C-AFCD385CE98CQ37635549-5CB56EF9-50FE-4C69-9CDD-6E2FD7856C0CQ37644820-83743A2B-717A-4594-9E46-71BE03DB81A9Q37732370-1CDF2F07-BA91-41F1-997C-F8796B8CB83DQ37832405-C6F5C63D-CBBB-4B17-AD20-D3159FA02D41
P2860
Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Added value of gadoxetic acid- ...... s of hepatocellular carcinoma.
@en
Added value of gadoxetic acid- ...... s of hepatocellular carcinoma.
@nl
type
label
Added value of gadoxetic acid- ...... s of hepatocellular carcinoma.
@en
Added value of gadoxetic acid- ...... s of hepatocellular carcinoma.
@nl
prefLabel
Added value of gadoxetic acid- ...... s of hepatocellular carcinoma.
@en
Added value of gadoxetic acid- ...... s of hepatocellular carcinoma.
@nl
P50
P356
P1433
P1476
Added value of gadoxetic acid- ...... is of hepatocellular carcinoma
@en
P2093
Hye-Suk Hong
P304
P356
10.1148/RADIOL.10091388
P407
P577
2010-05-01T00:00:00Z